BROADFIN CAPITAL
Broadfin Capital is a New-York-based company focused on investments in healthcare companies.
BROADFIN CAPITAL
Social Links:
Industry:
Finance
Status:
Active
Contact:
(212) 808-2460
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Easton Capital
Easton Capital is a New York-based investment group specializing in healthcare and life sciences companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-09 | Heron Therapeutics | Broadfin Capital investment in Post-IPO Equity - Heron Therapeutics | 76.5 M USD |
| 2021-04-27 | Arch Oncology | Broadfin Capital investment in Series C - Arch Oncology | 105 M USD |
| 2020-01-06 | Sonendo | Broadfin Capital investment in Venture Round - Sonendo | 85 M USD |
| 2018-05-17 | BioDelivery Sciences | Broadfin Capital investment in Post-IPO Equity - BioDelivery Sciences | 50 M USD |
| 2018-04-02 | Strata Skin Sciences | Broadfin Capital investment in Post-IPO Equity - Strata Skin Sciences | 17 M USD |
| 2016-06-03 | Iovance Biotherapeutics | Broadfin Capital investment in Post-IPO Equity - Iovance Biotherapeutics | 100 M USD |
| 2015-07-13 | Recro Pharma | Broadfin Capital investment in Post-IPO Equity - Recro Pharma | 16 M USD |
| 2015-06-22 | Ardelyx | Broadfin Capital investment in Post-IPO Equity - Ardelyx | 77.77 M USD |
| 2015-06-08 | Aralez Pharmaceuticals | Broadfin Capital investment in Post-IPO Equity - Aralez Pharmaceuticals | 350 M USD |
| 2015-02-19 | Advaxis | Broadfin Capital investment in Post-IPO Equity - Advaxis | 23 M USD |